International Nonproprietary Names for Pharmaceutical Substances (INN)
- Published in:
- 2011
- Publication type:
- Journal Article
Works matching IS 10109609 AND DT 2011 AND VI 25 AND IP 4
Results: 42
1
2
International Nonproprietary Names for Pharmaceutical Substances (INN).
- Published in:
- WHO Drug Information, 2011, v. 25, n. 4, p. 413
- Publication type:
- Article
3
Ritonaviri compressi Ritonavir tablets.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 4, p. 409
- Publication type:
- Article
4
Medroxyprogesterone injection.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 4, p. 406
- Publication type:
- Article
5
Artenimolum Artenimol.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 4, p. 403
- Publication type:
- Article
6
Pharmaceutical reform: improving performance and equity.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 4, p. 373
- Publication type:
- Article
7
Test for sterility.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 4, p. 391
- Publication type:
- Article
8
Test for bacterial endotoxins.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 4, p. 380
- Publication type:
- Article
9
Tablet friability.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 4, p. 379
- Publication type:
- Article
10
Bulk density and tapped density of powders.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 4, p. 374
- Publication type:
- Article
11
Chewable albendazole tablets.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 4, p. 400
- Publication type:
- Article
12
European Union and Andean Community trade agreements.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 4, p. 373
- Publication type:
- Article
13
Quality control methods for herbal materials.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 4, p. 372
- Publication type:
- Article
14
Guidelines for medicine donations.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 4, p. 372
- Publication type:
- Article
15
Marketing authorization of pharmaceutical products.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 4, p. 372
- Publication type:
- Article
16
New database of European experts.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 4, p. 371
- Publication type:
- Article
17
Lacosamide syrup: change in formulation.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 4, p. 371
- Publication type:
- Article
18
Voclosporin: withdrawal of marketing authorization application.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 4, p. 370
- Publication type:
- Article
19
Dronedarone: restricted use.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 4, p. 370
- Publication type:
- Article
20
Fidaxomicin approved for Clostridium difficile infection.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 4, p. 370
- Publication type:
- Article
21
First ever PUMA for buccal midazolam.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 4, p. 369
- Publication type:
- Article
22
Aprotinin: resumed marketing.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 4, p. 369
- Publication type:
- Article
23
Recommended composition of influenza vaccines: 2012 southern hemisphere.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 4, p. 369
- Publication type:
- Article
24
International Pharmaceutical Federation: pharmacovigilance seminar in India.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 4, p. 366
- Publication type:
- Article
25
Romiplostim: acute myelogenous leukaemia.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 4, p. 365
- Publication type:
- Article
26
Orlistat-containing medicines under review.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 4, p. 365
- Publication type:
- Article
27
Gadolinium: nephrogenic systemic fibrosis.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 4, p. 365
- Publication type:
- Article
28
Bevacizumab: ovarian failure.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 4, p. 364
- Publication type:
- Article
29
Strontium ranelate: cardiovascular and cutaneous toxicity.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 4, p. 364
- Publication type:
- Article
30
Neonates exposed to antipsychotic drugs: withdrawal symptoms.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 4, p. 363
- Publication type:
- Article
31
TNFα blockers: Legionella and Listeria.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 4, p. 362
- Publication type:
- Article
32
Ondansetron: QT prolongation.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 4, p. 361
- Publication type:
- Article
33
Drospirenone: increased risk of blood clots.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 4, p. 360
- Publication type:
- Article
34
Dasatinib: pulmonary arterial hypertension.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 4, p. 360
- Publication type:
- Article
35
Uromitexan: infant fatal gasping syndrome.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 4, p. 359
- Publication type:
- Article
36
Gonadotropin-releasing hormone: cardiovascular risk.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 4, p. 359
- Publication type:
- Article
37
Terpenic derivatives: new contraindications.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 4, p. 359
- Publication type:
- Article
38
Citalopram: dose-related cardiac risk.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 4, p. 358
- Publication type:
- Article
39
Lenalidomide: positive benefit-risk balance.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 4, p. 358
- Publication type:
- Article
40
Asenapine maleate: serious allergic reactions.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 4, p. 358
- Publication type:
- Article
41
Integration and application of equivalent regulatory assessments from other countries.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 4, p. 354
- By:
- Publication type:
- Article
42
Seven years of EU pharmaceutical regulation in Malta.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 4, p. 343
- By:
- Publication type:
- Article